IDENTIFICATION OF NEURONAL SUBTYPE-SPECIFIC SPLICE VARIANTS IN IPSC-DERIVED CELL MODELS OF ALS AND FTD
bit.bio
Presentation
Date TBA
Event Information
Poster Board
PS05-09AM-265
Poster
View posterAbstract
Amyotrophic lateral sclerosis (ALS) is characterised by the premature degeneration of upper and lower motor neurons. Many patients have cytoplasmic inclusions positive for the TDP-43 protein independent of the aetiology. TDP-43 is a nucleic acid-binding protein and is involved in gene regulation and the processing of RNA. Mutations in TARDBP, encoding TDP-43, can cause age-related TDP-43 aggregation and nuclear depletion, leading to pathogenic alternative mRNA splicing.
To discover neuron-specific TDP-43 targets, we used bulk RNA-sequencing to identify splice variants in our ioGlutamatergic and ioMotor Neurons carrying the heterozygous or homozygous M337V mutation in TARDBP. We used MAJIQ to compare the splice variants of TDP-43 WT/WT, TDP-43 M337V/WT and TDP-43 M337V/M337V neurons at different time points.
Comparative analysis of wild-type versus TDP-43 mutant cells revealed splice variants both unique to, and shared between, neuron subtypes. At day 30 of the culture, we identified multiple different splicing events when comparing wild-type to TDP-43 mutant cells. Previously reported splicing targets or ALS/FTD associated genes including SETD5, PRUNE2, CALD1 and DPP6, along with novel targets, were identified in this analysis.
Our data demonstrates that our iPSC-derived ALS/FTD cell models provide a platform to delineate TDP-43 function and identify cell specific target transcripts of TDP-43, and are valuable tools to study ALS/FTD and screen for drugs that can modulate the progression of these devastating diseases.
Recommended posters
HUMAN CORTICAL AND SPINAL CORD ORGANOIDS REVEAL CELL-TYPE–SPECIFIC CONSEQUENCES OF TDP-43 I383V MUTATION
Julia Sala Jarque, Sarah Eger, Ilana Krelstein, Yana Stepanyan, Andrew Longhini, Ana Barbara Cupajita, Pol Andres Benito, Mohamed El-Badry, Jorge Padro Esteve, Kenneth Kosik
MODELING TDP43 PROTEINOPATHY IN ALS USING PATIENT-DERIVED CORTICO-SPINAL ORGANOIDS
Erika Poggianti, Marilyn M. A. Salavarria, Susanna Basteri, Maria Teresa Dell'Anno, Alessio Zanelli, Gianmarco Ferri, Linda Ottoboni, Luciano Conti, Stefania Corti, Marco Onorati
AIR-LIQUID INTERFACE CORTICAL ORGANOIDS AS A PLATFORM TO STUDY TDP-43 PATHOLOGY IN ALS
Roberto Montoro Ferrer, Kaya Hopman, Mayte Z. Mars, Kimberly Siletti, Vamshidhar R. Vangoor, R. Jeroen Pasterkamp
DECIPHERING THE IMPACT OF TDP-43 LOSS-OF-FUNCTION ON ALTERNATIVE POLYADENYLATION IN THE ALS-FTD SPECTRUM
Irene Santos, Maria Carazo, Ane Velasco, Adolfo López de Munain, Lorea Blázquez
INVESTIGATING TRIPARTITE SYNAPSE PATHOLOGY IN ALS UTILIZING A HIPSC-DERIVED ORGANOID MODEL
Ahmad Jibai, Matthew Broadhead, Neela Murti, Laura Kibedi Makfalvi Varga, Channa Jakobs, Astrid Van der Geest, Kathryn Bowles, Jeroen Pasterkamp, Gareth Miles
IN VITRO AND IN VIVO CHARACTERIZATION OF HOW ALS MUTATION ON THE RNA-BINDING PROTEIN FUS CHANGES GENE EXPRESSION AND SYNAPSES IN HUMAN STEM CELL-DERIVED NEURONS
Kwok On Lai, Tian Wang, Flores Angelo, Ying Cai, Jacque Pak-Kan Ip